These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12766491)

  • 1. Mechanisms of cell death and disease: advances in therapeutic intervention.
    Packham G
    Apoptosis; 2003 Jun; 8(3):307-9. PubMed ID: 12766491
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth control of normal and malignant lymphocytes--cell death research from basic concepts to signal pathways and translation into the clinic.
    Debatin KM
    Klin Padiatr; 2009; 221(6):332-8. PubMed ID: 19890783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Function of Proto-oncogene Product PPM1D and Development of PPM1D Inhibitors for Cancer Chemotherapy].
    Kamada R; Chuman Y; Kozakai Y; Sakaguchi K
    Seikagaku; 2015 Oct; 87(5):531-8. PubMed ID: 26638620
    [No Abstract]   [Full Text] [Related]  

  • 4. Death on the slopes. Symposium on Cell Death Pathways.
    McPhee CK; Hill JH; Enoksson M
    EMBO Rep; 2009 Aug; 10(8):827-31. PubMed ID: 19609322
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of Cell Death and Disease: Advances in Therapeutic Intervention and Drug Discovery--ESH's Eighth International Conference. October 14-17, 2010, Cascais, Portugal.
    Vucic D
    IDrugs; 2010 Dec; 13(12):836-9. PubMed ID: 21154138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular perspective: Bcl-2 and apoptosis.
    Goodsell DS
    Stem Cells; 2002; 20(4):355-6. PubMed ID: 12110705
    [No Abstract]   [Full Text] [Related]  

  • 7. Stratified medicine for cancer therapy.
    Shaw EC; Johnson PW
    Drug Discov Today; 2012 Mar; 17(5-6):261-8. PubMed ID: 22493785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells.
    Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y
    Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesyl transferase inhibitors.
    Li T; Sparano JA
    Cancer Invest; 2008 Aug; 26(7):653-61. PubMed ID: 18665473
    [No Abstract]   [Full Text] [Related]  

  • 10. The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance.
    Rudzińska M; Parodi A; Soond SM; Vinarov AZ; Korolev DO; Morozov AO; Daglioglu C; Tutar Y; Zamyatnin AA
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early work on the function of Bcl-2, an interview with David Vaux.
    Vaux D
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S28-32. PubMed ID: 15118765
    [No Abstract]   [Full Text] [Related]  

  • 12. Apoptosis and non-apoptotic deaths in cancer development and treatment response.
    de Bruin EC; Medema JP
    Cancer Treat Rev; 2008 Dec; 34(8):737-49. PubMed ID: 18722718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights on oxidative stress in cancer.
    Visconti R; Grieco D
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):240-5. PubMed ID: 19333869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apoptosis: bcl-2 as a key protein for programmed cell death].
    Amling M; Pösl M; Bäsler I; Delling G
    Pathologe; 1994 Dec; 15(6):331-6. PubMed ID: 7855101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects of the apoptotic pathway as therapeutic target against cancer.
    Mashima T; Tsuruo T
    Drug Resist Updat; 2005 Dec; 8(6):339-43. PubMed ID: 16338161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis: a new pharmacodynamic endpoint.
    Au JL; Panchal N; Li D; Gan Y
    Pharm Res; 1997 Dec; 14(12):1659-71. PubMed ID: 9453051
    [No Abstract]   [Full Text] [Related]  

  • 17. Mitochondria and apoptosis: new therapeutic targets.
    Hockenbery DM; Giedt CD; O'Neill JW; Manion MK; Banker DE
    Adv Cancer Res; 2002; 85():203-42. PubMed ID: 12374287
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein kinase C: implications for cancer prevention and treatment.
    Weinstein IB
    Mt Sinai J Med; 1992 Oct; 59(5):387-90. PubMed ID: 1435832
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell Death and Cancer Therapy: Don't Forget to Kill the Cancer Cell!
    Letai A
    Clin Cancer Res; 2015 Nov; 21(22):5015-20. PubMed ID: 26567360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional targeting of the MUC1 oncogene in human cancers.
    Kufe DW
    Cancer Biol Ther; 2009 Jul; 8(13):1197-203. PubMed ID: 19556858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.